Caltrate, the bone and joint health supplement brand from Haleon, has reported double-digit revenue growth in Q1 largely due to strong demand from China.
Haleon says that its vitamins minerals supplements (VMS) portfolio has gained shares in an overall declining market in FY23, led by growth in its core VMS brands Centrum, Caltrate, and Emergen-C, with the CEO saying that the firm is “optimistic” on the...
A deep understanding of human biology, tapping on trusted science and key partnerships with researchers, start-ups and suppliers are key in achieving new breakthroughs in nutraceuticals innovation, Haleon’s chief of R&D told NutraIngredients-Asia...
Haleon’s vitamins, minerals, and supplements (VMS) sales in Q3 was led by Centrum’s double-digit growth in China, the US, and Middle East, which has offset the decline seen in Emergen-C, its other power brand.
Haleon, the company behind vitamin brands Centrum and Caltrate, said VMS revenue was down 0.5 per cent in the first six months of this year, with a decline in the US offset by growth in Asia Pacific and Europe.
Haleon has reported high single digit revenue growth in its vitamin and mineral supplements (VMS) category across Asia-Pacific in Q1 this year, due to the demand for Centrum and Caltrate especially in China, South East Asia, and Taiwan.
Haleon, the maker of vitamin and mineral supplement brands Centrum and Caltrate, said revenue growth haw gone up by over 20 per cent for its VMS portfolio in South East Asia, Taiwan, and India.
Haleon, formerly GSK Consumer Health, has entered into a partnership with CREA – an e-commerce enabler to increase the presence brands such as Centrum across Thailand’s e-commerce and social media platforms.
The vitamin and mineral (VMS) category will continue to trend towards meeting the needs of individuals of different ages, life stages, and gender, according to GSK consumer healthcare, which highlighted how this is driving its NPD.
